NewLink Genetics reports second quarter 2016 financial results
NewLink Genetics reported a net loss of $32.4 million or ($1.12 ) per diluted share for the 2016 second quarter versus a net loss of $14.1 million or ($0.49) per diluted share for the same 2015 period. NewLink Genetics ended the quarter on June 30, 2016, with cash and equivalents of $160.5 million. July 29, 2016